Logo

Course

Best of ACTHIV® 2026: Fat, Fibrosis and HIV - Pearls on MASLD Management

Details

Published Date: 09/15/2026

Expiration Date: 09/15/2027

CE Credit: CNE: 0.5CPE: 0.5

Description

Selected by attendees and the program planning committee as one of the high-impact sessions of the ACTHIV® 2026 conference for the interprofessional HIV care team, this activity equips learners with practical, evidence-based approaches to screen and risk stratify patients for MASLD/MASH, incorporate lifestyle and pharmacologic management into clinical practice, and identify patients who would benefit from specialty referral.

Presenter(s)

Lesley Miller,MD, FACP

Lesley Miller, MD, FACP is a Professor of Medicine at Emory University. She is the Medical Director of the Grady Liver Clinic, a hepatitis C clinic for underserved patients at Grady Health System in Atlanta, GA. Dr. Miller leads internationally recognized HCV screening and treatment programs, focusing on unique treatment models aimed at HCV elimination. Dr Miller serves as a medical expert for the GA Department of Public Health Viral Hepatitis ECHO program and is a member of several national HCV-related steering committees. She has been recognized as a Hepatitis Elimination Champion by the Task Force for Global Health.

Learning Objectives

  • Identify who and how to screen and risk stratify for MASLD/MASH.
  • Describe lifestyle and pharmacologic management for MASLD/MASH.
  • Identify who to refer for specialty care.

Continuing Education Credit Information